Expression of Btk and NFκB in acute myeloid leukemia cells and its significance.
10.7534/j.issn.1009-2137.2013.01.006
- Author:
Shan-Dong TAO
1
;
Yuan DENG
;
Zheng-Mei HE
;
Yue CHEN
;
Zhi-Kui DENG
;
Yuan-Yuan LI
;
Jia-Bin ZHU
;
Bang-He DING
;
Liang YU
Author Information
1. Department of Hematology, Nanjing Medical University, Huai'an, Jiangsu Province, China.
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Aged;
Child;
Child, Preschool;
Female;
Humans;
Leukemia, Myeloid, Acute;
genetics;
pathology;
Male;
Middle Aged;
NF-kappa B;
genetics;
Prognosis;
Protein-Tyrosine Kinases;
genetics;
RNA, Messenger;
genetics;
Young Adult
- From:
Journal of Experimental Hematology
2013;21(1):25-28
- CountryChina
- Language:Chinese
-
Abstract:
This study was purposed to investigate the expression of Btk and NFκB in acute myeloid leukemia (AML) cells and its significance. Bone marrow mononuclear cell specimens were taken from 14 AML patients who were in new diagnosis and complete remission respectively, the expressions of Btk and NFκB at mRNA and protein levels were detected by RT-PCR and Western blot, respectively. The results showed that Btk and NFκB expressed in all the samples at RNA and protein levels. At protein level, Btk and NFκB expressions were higher in the cells from newly diagnosed AML patients than that in the cells from patients in complete remission stage (P < 0.05). It is concluded that Btk and NFκB may play an important role in the development and progression of AML, they may be used as potential therapeutic targets of AML and used in predicting the prognosis.
